44 related articles for article (PubMed ID: 11528115)
1. Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.
Kang XL; Zou H; Pang LJ; Hu WH; Zhao J; Qi Y; Liu CX; Hu JM; Tang JX; Li HA; Liang WH; Yuan XL; Li F
Int J Clin Exp Pathol; 2015; 8(4):3636-47. PubMed ID: 26097545
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.
Jiang F; Richter J; Schraml P; Bubendorf L; Gasser T; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 1998 Nov; 153(5):1467-73. PubMed ID: 9811338
[TBL] [Abstract][Full Text] [Related]
3. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data.
Baudis M
BMC Cancer; 2007 Dec; 7():226. PubMed ID: 18088415
[TBL] [Abstract][Full Text] [Related]
5. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.
Sanders ME; Mick R; Tomaszewski JE; Barr FG
Am J Pathol; 2002 Sep; 161(3):997-1005. PubMed ID: 12213728
[TBL] [Abstract][Full Text] [Related]
6. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
[TBL] [Abstract][Full Text] [Related]
7. Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease.
Millet-Boureima C; He S; Le TBU; Gamberi C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920158
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Eichenauer T; Shadanpour N; Kluth M; Göbel C; Weidemann S; Fraune C; Büscheck F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Burandt E; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz T
World J Surg Oncol; 2020 Jun; 18(1):128. PubMed ID: 32534597
[TBL] [Abstract][Full Text] [Related]
9. Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization.
Gowrishankar B; Cahill L; Arndt AE; Al-Ahmadie H; Lin O; Chadalavada K; Chaganti S; Nanjangud GJ; Murty VV; Chaganti RS; Reuter VE; Houldsworth J
BJU Int; 2014 Dec; 114(6):881-90. PubMed ID: 24467611
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of large parathyroid adenomas.
Sulaiman L; Nilsson IL; Juhlin CC; Haglund F; Höög A; Larsson C; Hashemi J
Endocr Relat Cancer; 2012 Jun; 19(3):389-407. PubMed ID: 22454399
[TBL] [Abstract][Full Text] [Related]
11. Parkin gene alterations in ovarian carcinoma from northern Indian population.
Mehdi SJ; Ali A; Rizvi MM
Pathol Oncol Res; 2011 Sep; 17(3):579-86. PubMed ID: 21221875
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
Looyenga BD; Furge KA; Dykema KJ; Koeman J; Swiatek PJ; Giordano TJ; West AB; Resau JH; Teh BT; MacKeigan JP
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1439-44. PubMed ID: 21220347
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression.
Zhang Z; Wondergem B; Dykema K
Adv Bioinformatics; 2010; 2010():428325. PubMed ID: 20671976
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.
Mehdi SJ; Alam MS; Batra S; Rizvi MM
Med Oncol; 2011 Dec; 28(4):1520-6. PubMed ID: 20652448
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
[TBL] [Abstract][Full Text] [Related]
16. [Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].
Mertz KD; Tchinda J; Küfer R; Möller P; Rubin MA; Moch H; Perner S
Urologe A; 2006 Mar; 45(3):316-8, 320-2. PubMed ID: 16465524
[TBL] [Abstract][Full Text] [Related]
17. Advanced molecular cytogenetics in human and mouse.
Dorritie K; Montagna C; Difilippantonio MJ; Ried T
Expert Rev Mol Diagn; 2004 Sep; 4(5):663-76. PubMed ID: 15347260
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 6 suffers frequent and multiple aberrations in thymoma.
Inoue M; Marx A; Zettl A; Ströbel P; Müller-Hermelink HK; Starostik P
Am J Pathol; 2002 Oct; 161(4):1507-13. PubMed ID: 12368223
[TBL] [Abstract][Full Text] [Related]
19. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization.
Reutzel D; Mende M; Naumann S; Störkel S; Brenner W; Zabel B; Decker J
Cytogenet Cell Genet; 2001; 93(3-4):221-7. PubMed ID: 11528115
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
